In addition to acting directly on NF-κB, it has been shown that, in tumors, RES also acts on the PI3K/AKT pathway by inhibiting it, thus regulating cellular differentiation, growth, and proliferation of tumor cells [142,143,144]. The gene discussed is NFKB1; the disease is neoplasm.